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markers and apoptosis in the offspringś heart of diabetic rats, Reproductive Toxicology
(2020), doi: https://doi.org/10.1016/j.reprotox.2020.05.002
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2020 Published by Elsevier.
 1 
Olive oil supplementation prevents extracellular matrix deposition and reduces 
prooxidant markers and apoptosis in the offspring´s heart of diabetic rats.  
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 Maternal diabetes programs cardiovascular diseases  
 Diabetic rats were fed an olive oil-enriched diet during pregnancy  
 This diet prevented increased collagen deposition in the offspring´s heart 
 This diet reduced prooxidant markers in the offspring´s heart  





















Maternal diabetes induces fetal programming of cardiovascular diseases. Diabetes 
induced-cardiac fibrosis is a process that may start in utero and may be related to the 
prooxidant/proinflammatory environment. The aim of this study was to investigate the 
effect of a maternal diet enriched in olive oil on the levels of components and regulators 
of the extracellular matrix, on prooxidant markers and on apoptosis rate in the heart of 
21-day-old offspring of diabetic rats. Maternal diabetes was induced by neonatal 
administration of streptozotocin. During pregnancy, diabetic and control rats were fed 
with diets supplemented or not with 6% olive oil. The heart of the offspring was studied 
at 21 days of age. We found increased deposition of collagen IV and fibronectin in the 
offspring´s heart of diabetic rats, which was prevented by the maternal diets enriched in 
olive oil. Increases in connective tissue growth factor were also prevented by the 
maternal diets enriched in olive oil. Prooxidant markers as well as apoptosis, which 
were increased in the heart of the offspring of diabetic rats, were prevented by the 
maternal olive oil dietary treatment. Our findings identified powerful effects of a 
maternal diet enriched in olive oil on the prevention of increased extracellular matrix 
deposition and increased prooxidant markers in the heart of 21-day-old offspring of 










Abbreviations: Matrix metalloproteinase, MMP; connective tissue growth factor, 
CTGF; peroxisome proliferator receptor, PPAR.  
 












Diabetes in pregnancy increases the risks of adverse outcomes in the mother, the 
placenta, the fetus and the offspring, both in the perinatal period and in the long term [1, 
2]. In different gestational diseases, including maternal diabetes, cardiovascular diseases 
are programmed in utero [3-5]. Experimental models of diabetes and pregnancy are 
useful to address the underlying mechanisms of fetal programming [6]. Our previous 
studies performed in rats have shown that maternal diabetes induces a 
prooxidant/proinflammatory intrauterine environment, which affects the development of 
different fetal organs, including the fetal heart, leading to adverse consequences in the 
offspring´s later life [7]. In human diabetic pregnancies, the intrauterine compartment is 
characterized by a prooxidant/proinflammatory state [8]. As a 










extracellular matrix remodeling [9, 10], a different deposition of extracellular matrix 
components may be programmed by maternal diabetes.  
The extracellular matrix is crucial in cardiac development and function, and its altered 
remodeling has been found profoundly involved in cardiovascular diseases [10]. 
Fibrosis is increased in the heart of diabetic patients, and the mechanisms involved in 
the deposition of extracellular matrix components are still unclear [11]. A main 
regulator of deposition of extracellular matrix components is the matricellular protein 
connective tissue growth factor (CTGF), while main regulators of their degradation are 
matrix metalloproteinases (MMPs) [12, 13].  
In recent studies, we addressed the effects of the administration of the mitochondrial 
antioxidant idebenone to diabetic pregnant rats, showing its ability to prevent maternal 
diabetes-induced changes in CTGF levels and MMPs in the heart of 21-day-old 
offspring [14]. Whether maternal diets enriched in olive oil can exert these beneficial 
effects is unknown. In humans, diets enriched in extra-virgin olive oil have been shown 
to exert potent antioxidant/anti-inflammatory effects in cardiovascular diseases [15, 16]. 
The PREDIMED study showed that enhanced extra-virgin olive oil consumption is 
associated with reduced risks of cardiovascular diseases and mortality in patients with 
high cardiovascular risks [17]. Indeed, due to the cardiovascular benefits of the 
Mediterranean diet, with olive oil as a main component, olive oil has been proposed as a 
valuable health-promoting nutrient [16, 17]. In pregnancy, diets enriched in olive oil 
have been shown to reduce the risk of gestational diabetes in the general population 
[18]. In experimental models of diabetes and pregnancy, treatments with olive oil have 
been found to activate peroxisome proliferator activated receptors (PPAR) pathways 
and lead to antioxidant and metabolic effects in adult offspring [19], beneficial effects 










maternal diets enriched in olive oil are able to prevent maternal diabetes-induced 
changes in components and regulators of the extracellular matrix, to reduce prooxidant 
markers and to prevent increased apoptosis in the heart of the 21-day-old offspring of 
diabetic rats. 
 
2. Materials and methods 
 
2.1. Animals  
 
Twenty-eight Albino Wistar rats were obtained from the certified animal facilities of the 
School of Exact and Natural Sciences, University of Buenos Aires (UBA), Argentina. 
The rats were housed in the animal facilities of our Institution (CEFYBO-CONICET-
UBA), with a 12 h light and 12 h dark cycle, and fed ad libitum with commercial rat 
chow (Asociación Cooperativa Argentina, Buenos Aires, Argentina). A mild diabetic rat 
model was induced by injecting 2-day-old neonates with streptozotocin (90 mg/kg, s.c, 
Sigma-Aldrich, St. Louis, MO, USA, diluted in citrate buffer 0.05M pH 4.5, Sigma-
Aldrich), as previously [6, 20]. Control rats were injected with citrate buffer alone. The 
diabetic state was confirmed in 2-month-old rats prior to mating. Rats were considered 
diabetic when they presented fasting glycemia values higher than 130 mg/dl. The 
animal protocol was approved by the Institutional Committee for the Care and Use of 
Experimental Animals (CICUAL, Resolution CD Nº 1497/2013), School of Medicine, 
UBA, complied with the ARRIVE guidelines and was conducted according to the Guide 
for the Care and Use of Laboratory Animals, US National Institutes of Health (NIH 












2.2. Experimental design and sample collection 
 
Fourteen control and fourteen diabetic female adult rats were mated with control adult 
males. The presence of sperm cells in vaginal smears confirmed the first day of 
pregnancy. From the first day of pregnancy until parturition, the control and diabetic 
rats received or not the following diets: a) a standard diet (commercial rat chow) or b) a 
standard diet enriched in 6% olive oil. The diet composition was: a) Standard diet (g/100 
g): carbohydrates (50); proteins (25); fats (5), major fatty acids 16:0 (0.58), 18:0 (0.16), 
18:1 (1.27), 18:2 (1.99), 18:3 (0.73) and b) Olive oil-supplemented diet (g/100 g): 
carbohydrates (48); proteins (24); fats (11), major fatty acids 16:0 (1.55), 18:0 (0.26), 18:1 
(5.77), 18:2 (2.41), 18:3 (0.57). After parturition, all animals received the described 
standard diet. Each litter was adjusted to 10 offspring, which were euthanized at 21 days 
of age. Pooled blood per sex per litter was collected in citrate buffer tubes for further 
determination of glucose levels in plasma. The hearts of male and female offspring from 
each control and diabetic mother were explanted (n=7 litters, 36 male and 34 female 
offspring in the control group; 35 male and 35 female offspring in the olive oil-
supplemented control group; 36 male and 34 female offspring in the diabetic group; and 
36 male and 34 female offspring in the olive oil-supplemented diabetic group). From 
each litter and sex, hearts explanted from two offspring, randomly selected, were 
prepared for immunohistochemical and TUNEL analyses.  The remaining hearts of each 
sex and litter were conserved at -80ºC for the determination of nitrates/nitrites (an index 
of nitric oxide (NO) production) and thiobarbituric acid reactive substances (TBARS, 











2.3. Immunohistochemical analysis 
 
Immunostaining of collagen IV, fibronectin, CTGF, MMP-2 and nitrotyrosine (an index 
of peroxynitrite-induced damage [8]) was performed in the heart of 21-day-old 
offspring of control and diabetic rats from the olive oil-supplemented and non-
supplemented experimental groups (randomly selected hearts from n=7 different F0 
mothers in each group). The hearts were paraffinized and serially sliced in 5-μm-thick 
sections. Then, sections were deparaffinized with xylol, rehydrated through a graded 
series of ethanol and the endogenous peroxidase activity was blocked with H2O2 0.3%. 
The sections were marked using the corresponding primary antibodies: anti-collagen 
type IV (rabbit polyclonal antibody, 1:400, Santa Cruz Biotechnology, CA, USA), anti-
fibronectin (rabbit polyclonal antibody, 1:250, DAKO Diagnostics, CA, USA), anti-
CTGF (goat polyclonal antibody, 1:200, Santa Cruz Biotechnology), anti-MMP-2 (goat 
polyclonal antibody, 1:200 dilution, Santa Cruz Biotechnology) and anti-nitrotyrosine 
(mouse monoclonal antibody, 1:4000 dilution, Millipore, Darmstadt, Germany). The 
Avidin-Biotin Complex system (Vectastain Elite ABC kit, Vector Laboratories, 
Burlingame, CA, USA) was then followed using the corresponding biotinylated 
antibodies (anti-goat IgG, anti-mouse IgG- rat absorbed or anti-rabbit IgG, 1:200 
dilution, Vector Laboratories) and developed with 3,3’-diaminobenzidine, as reported 
previously [20]. Control sections were performed by omitting the primary antibody and 
by replacing the primary antibody by a pooled serum of the same species that contains a 
spectrum of the IgG subclasses (Vector Laboratories). The slides immunostained with 
anti-CTGF antibody were also stained with hematoxylin. Using light microscopy, three 










Immunoreactivity intensity was quantified with the ImageProPlus software. Data are 
shown as relative to a value of 1, assigned to the control.  
 
2.4. Nitric oxide production  
 
The production of NO was determined by measuring the concentration of its stable 
metabolites nitrates/nitrites in the heart of 21-day-old offspring of control and diabetic 
rats from the olive oil-supplemented and non-supplemented experimental groups (2-4 
pooled hearts from n=7 different F0 mothers in each group). Briefly, as previously done  
[21], each heart was homogenized in 1 ml Tris-HCl buffer (0.1 M, pH: 7.4), and an 
aliquot was separated for protein measurement. Nitrates in the supernatant were reduced 
to nitrites by using nitrate reductase, and then, total nitrites were determined using a 
commercial assay kit (Cayman Chemical Co. Ann Arbor, MI, USA), according to the 
manufacturer´s instructions. 
 
2.5. Lipoperoxidation analysis 
 
Lipoperoxidation was assessed by evaluating the concentrations of TBARS, a method 
widely used to assess peroxidation of fatty acids [22], in the heart of 21-day-old 
offspring of control and diabetic rats from the olive oil-supplemented and non-
supplemented experimental groups (2-4 pooled hearts from n=7 different F0 mothers in 
each group). Briefly, as previously done [21], each heart was homogenized in Tris-HCl 
buffer (0.1 M, pH: 7.4). The homogenate was added with 40% trichloroacetic acid 
(Merck Darmstadt, Germany). After centrifugation, an equal volume of thiobarbituric 










heated at 95ºC. After cooling, TBARS were measured spectrophotometrically at 540 
nm. Different concentrations of malondialdehyde (Sigma-Aldrich) subjected to the same 
conditions as the tissue homogenates were used as standards.  
 
2.6. Apoptosis analysis 
 
To study apoptosis in the heart of 21-day-old offspring of control and diabetic rats from 
the olive oil-supplemented and non-supplemented experimental groups, we used the 
same paraffinized samples prepared for immunohistochemical studies (randomly 
selected hearts from n=7 different F0 mothers in each group), a terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay was 
performed using an in situ cell apoptosis detection kit (DeadEnd Fluorometric 
TUNEL System, Promega, Durham, NC, USA) according to the manufacturer’s 
instructions, as previously [23]. Three entire sections per heart were examined by two 
skilled blinded observers under fluorescent microscopy (Nikon Eclipse E200) and 
photographed (Nikon DS-Fi1). The number of positive cells was quantified using the 
Image J software (NIH, Bethesda, MA, USA).  
 
2.7. Statistical analysis 
 
Data are presented as the mean ± SD. Groups were compared by two-way ANOVA in 














3.1. Effect of maternal olive oil supplementation on extracellular matrix components 
and deposition regulators in the offspring´s heart of diabetic rats  
 
A mild diabetic rat model induced by neonatal streptozotocin administration, previously 
characterized during pregnancy [6], was used to evaluate the offspring´s heart. Glycemia 
values in the pregnant diabetic rats at term were increased in both the non-supplemented 
and olive oil-supplemented diabetic groups compared to controls (p<0.001, Table 1). The 
offspring of diabetic animals showed sex-dependent changes in glycemia at 21 days of 
age. Female offspring showed no changes in glycemia in both the olive oil-
supplemented and non-supplemented groups, compared to controls (Table 1). 
Differently, the male offspring of diabetic rats showed increased glycemia (p<0.05 vs 
control), an alteration that was prevented by the maternal dietary olive oil 
supplementation during pregnancy (p<0.01 vs non-supplemented diabetic groups) 
(Table 1).  
In the heart of the 21-day-old offspring, main components of the extracellular matrix 
were evaluated. The deposition of collagen IV was increased in the heart of female and 
male offspring of diabetic rats (p<0.05 vs control), an alteration prevented by the 
maternal dietary supplementation with olive oil (p<0.01 vs non-supplemented diabetic 
group) (Fig. 1). Fibronectin levels showed no changes in the heart of female offspring 
of diabetic rats in both the olive oil-supplemented and non-supplemented groups 
compared to controls (Fig. 2). Differently, fibronectin levels were increased in the heart 
of male offspring of diabetic rats compared to controls (p<0.01), an alteration prevented 
by the maternal dietary supplementation with olive oil (p<0.001 vs non-supplemented 









CTGF, a profibrotic matricellular protein [12], was found increased in the heart of 
female offspring of diabetic rats (p<0.05 vs control), although no changes were 
observed when the olive oil-supplemented diabetic group was compared to controls 
(Fig. 3). A 2-fold increase in CTGF was observed in the heart of male offspring of 
diabetic rats (p<0.001 vs control), an alteration prevented by the maternal dietary 
supplementation with olive oil (p<0.001 vs non-supplemented diabetic group) (Fig. 3). 
On the other hand, the protein levels of the proteolytic enzyme MMP-2 showed no 
changes in the heart of male and female offspring of the non-supplemented diabetic 
groups (Fig. 4), but were reduced in the heart of male and female offspring of the olive 
oil-supplemented diabetic groups (p<0.01 vs non-supplemented diabetic group)  (Fig. 
4).  
 
3.2. Effect of maternal olive oil supplementation on prooxidant markers and on 
apoptosis in the offspring´s heart from diabetic rats  
 
Aberrant extracellular matrix remodeling is highly related to the 
prooxidant/proinflammatory environment [9, 13]. In this work, we measured the levels 
of  nitrated proteins, an index of the damage induced by the potent oxidant 
peroxynitrites [24], finding no changes in the heart of female offspring of diabetic rats 
compared to controls, but a reduction in the heart of female offspring of the olive oil-
supplemented diabetic group (p<0.001 vs non-supplemented diabetic group) (Fig. 5). 
Differently, a 3-fold increase in nitrated protein levels was found in the heart of male 
offspring of diabetic rats (p<0.001 vs control), an alteration prevented by maternal 
dietary supplementation with olive oil (p<0.001 vs non-supplemented diabetic group) 










species [24], we next measure nitrates/nitrites, an index of nitric oxide production, and 
TBARS, a measurement of lipoperoxidation, a marker of oxidative stress. In the heart of 
the female offspring, no changes in nitrates/nitrites were observed either in the non-
supplemented or the olive oil-supplemented diabetic groups compared to controls (Fig. 
6). Differently, in the heart of the male offspring, nitrates/nitrites showed increases in 
the non-supplemented diabetic group (p<0.05 vs control), although no changes were 
observed in the olive oil-supplemented diabetic group compared to controls (Fig. 6A). 
TBARS showed increased levels in the heart of both the female and male offspring of 
diabetic rats compared to controls (p<0.01), alterations prevented by the maternal 
dietary supplementation with olive oil (p<0.01 vs non-supplemented diabetic group) 
(Fig. 6B).   
Finally, regarding apoptosis, the number of apoptotic cells was increased in the heart of 
both the female and male offspring of diabetic rats compared to controls (p<0.05), an 
alteration prevented by the maternal dietary supplementation with olive oil (p<0.001 vs 




The current study demonstrates sex-dependent alterations in the heart of the 
offspring of diabetic rats at a young age, which include aberrant deposition of 
components of the extracellular matrix, increased levels of the matricellular protein 
CTGF, enhanced prooxidant mediators and increased apoptosis, alterations prevented 
by the maternal diets enriched in olive oil.  
The burden of metabolic diseases and their recognized involvement in the 










find feasible treatments to prevent fetal programming in metabolic gestational diseases 
[1, 25]. In experimental models of diabetes and pregnancy, programming of metabolic 
and cardiovascular diseases is induced, allowing to address putative maternal treatments 
to prevent anomalies in the offspring´s heart [7]. In this study, we evaluated the 
offspring of diabetic rats at postnatal day 21 and found that males but not females 
showed hyperglycemia, a metabolic alteration that was prevented by the dietary 
treatment with olive oil. In agreement, in the male adult offspring of diabetic animals, 
we have previously shown that hyperglycemia is prevented by the maternal olive oil-
supplemented diet, although hyperglycemia remains in the female adult offspring [19]. 
Many studies have shown the increased susceptibility in males compared to females to 
metabolic diseases, the role of sex hormones associated with these differences and the 
different effects of pharmacological treatments according to sex [26-29]. Moreover, 
several studies have shown that sex-dependent changes arise before puberty, and even 
in utero in a wide range of diseases, including metabolic diseases [30]. It has also been 
shown that the levels of growth factors and adipokines in cord blood change according 
to the fetal sex, suggesting different responses to maternal glycemia and different 
mechanisms involved in the programming of metabolic diseases [31]. Indeed, 
mechanisms of programming have been found related to sex in humans and different 
animal models of metabolic diseases [32]. Likely involved in programming of 
metabolic diseases, the pancreas is highly susceptible to maternal hyperglycemia and 
the development in utero of this organ is influenced by sex hormones [28, 33]. Whether 
the pancreas is differentially affected by sex during development in the experimental 
model evaluated deserves further research. In this study, we focused in the offspring´s 










evaluated, likely generated in utero and possibly influenced by the increased glycemia 
evidenced in the 21-day-old male offspring of diabetic rats.  
In the heart, the extracellular matrix is crucial in cardiac homeostasis, being 
fibrosis associated with the diabetic disease in both patients and experimental models 
[10, 11]. In this work, we focused in the putative changes in extracellular matrix 
components and deposition regulators induced in the offspring´s heart by maternal 
diabetes. Increased collagen deposition in the heart of males and females and 
fibronectin deposition in the heart of males were prevented by the maternal diets 
enriched in olive oil in the 21-day-old offspring of diabetic rats. Out of pregnancy, 
many cardiovascular benefits of an olive oil-enriched diet have been identified [15, 17], 
although its effects as a regulator of components of the extracellular matrix had not been 
previously addressed. In this work, we identified the ability of the olive oil-enriched diet 
to prevent aberrant deposition of extracellular matrix in the offspring´s heart of diabetic 
rats, a result possibly relevant in the prevention of programming of cardiovascular 
diseases. 
 To address putative regulators of the observed changes in the extracellular 
matrix components, we addressed the levels of CTGF, which were increased in the heart 
of the male and female offspring from diabetic rats compared to controls, an increase 
that was more marked in males and was prevented by the maternal diet enriched in olive 
oil. These results are significant, as CTGF is considered a marker of cardiac 
dysfunction, and its levels are increased in different models of heart failure, fibrosis and 
cardiac hypertrophy [34, 35]. As a limitation of this work, we were not able to perform 
functional analysis of the offspring´s hearts. Previous studies have shown the ability of 
a maternal treatment with idebenone to prevent increased CTGF levels in the heart of 










involved in the beneficial effects observed. Indeed, out of pregnancy, many studies have 
addressed the antioxidant effects of olive oil in cardiovascular diseases [15, 16]. 
Moreover, in experimental models of diabetes and pregnancy, diets enriched in olive oil 
have shown antioxidant effects in different fetal organs, including the fetal heart [21, 
36], beneficial effects that may be involved in the antioxidant effects observed in the 
heart of the 21-day-old offspring of diabetic rats. In this work, we found no changes in 
MMP-2 levels in the heart of 21-day-old offspring of diabetic rats, although their 
reduction in the groups that received the olive oil supplementation suggests their 
putative contribution to the extracellular matrix remodeling observed under this 
maternal treatment. MMP-2 is involved in development as well as in tissue remodeling 
and many different pathological processes [37]. Our previous studies have shown 
increased MMP-2 activity in placentas and fetuses from diabetic rats at mid pregnancy, 
an alteration regulated by maternal diets enriched in olive oil [20]. Increased MMP-2 
activity is involved in pathogenic mechanisms in the heart and related to increased 
oxidative stress [10, 38, 39]. Although unchanged at the offspring age evaluated, MMP-
2 has been previously found increased in the heart of adult offspring of diabetic rats 
[38]. Thus, more marked impairments as those that arise in youth are likely needed to 
alter the levels of MMP-2 in the offspring of the mild diabetic rat model evaluated.  
Prooxidant/proinflammatory markers, including nitrated proteins and NO 
overproduction, which are enhanced only in the heart of male offspring of diabetic rats, 
and TBARS, which are increased in the heart of male and female offspring of diabetic 
rats, showed reduced levels with the maternal treatment with olive oil, indicating the 
ability of this treatment to exert potent antioxidant and anti-inflammatory effects in the 
offspring´s heart at the postnatal stage evaluated. Antioxidant/anti-inflammatory effects 










Moreover, possibly related to the ability of the olive oil-enriched diet to prevent a 
prooxidant/proinflammatory environment, we observed that the increased number of 
apoptotic cells in the heart of the 21-day-old offspring of diabetic rats was prevented by 
the maternal diet enriched in olive oil. In this regard, there is a close link between 
oxidative stress, inflammation and apoptosis [41, 42]. Previous studies have shown that 
diabetes induces cardiomyocyte apoptosis, whereas in vitro studies have addressed the 
ability of oleic acid to protect vascular smooth muscle cells from apoptosis induced by 
prooxidant/proinflammatory mediators [41, 43, 44]. As cardiac apoptosis is believed to 
play a causal role in heart diseases [42], the observed effects of the olive oil-enriched 
maternal diet to reduce apoptosis in the offspring´s heart are likely relevant.  
The ability of the olive oil-enriched diet to exert beneficial effects on the 
offspring´s heart is likely the result of the in utero effects of this diet. Indeed, 
prooxidant and proinflammatory markers as well as PPARs and mTOR signaling 
pathways are regulated by this dietary treatment in the placenta, which may indirectly 
benefit the fetal heart [20, 45]. Moreover, we have previously found that, at the fetal 
stage, both lipoperoxidation, which is increased in hearts from male fetuses of diabetic 
rats, and  nitric oxide overproduction, which is increased in hearts from male and female 
fetuses of diabetic rats, are prevented by maternal diets enriched in olive oil [21]. This 
beneficial effect has been related to the ability of this diet to activate PPAR pathways 
and induce antioxidant/anti-inflammatory pathways [21, 36]. Thus, possibly, the 
observed ability of the olive oil-supplemented diet to reduce oxidative stress markers in 
the heart of the 21-day-old offspring is the result of antioxidant effects exerted in utero, 
which in turn lead to the prevention of the adverse programming observed in the 














The current study demonstrates the ability of a maternal diet enriched in olive oil 
to prevent anomalies in deposition of components of the extracellular matrix, to regulate 
the levels of the profibrotic mediator CTGF, to reduce prooxidant markers and to 
prevent increased apoptosis in the heart of the offspring of diabetic rats at an early 
postnatal stage, suggesting putative long-term cardiovascular benefits. As an olive oil-
enriched diet has been found highly beneficial to cardiovascular health in non-pregnant 
subjects, the possibility that an olive oil-enriched diet prevents long-term cardiovascular 
diseases in the offspring of diabetic subjects is an issue that warrants further research.  
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Fig. 1. Immunostaining of collagen IV in the heart of 21-day-old female and male 
offspring from control and diabetic rats. Representative microphotographs of the 
ventricles and densitometry analysis are shown (400X). CO: Offspring of non-
supplemented control rats, CO-OO: Offspring of Olive Oil-supplemented control rats, 










supplemented diabetic rats. Values represent mean ± SD obtained from 7 rats from 
different F0 mothers in each experimental group. Different letters denote significant 
differences between groups, p < 0.05. 
  
Fig. 2. Immunostaining of fibronectin in the heart of 21-day-old female and male 
offspring from control and diabetic rats. Representative microphotographs of the 
ventricles and densitometry analysis are shown (400X). CO: Offspring of non-
supplemented control rats, CO-OO: Offspring of Olive Oil-supplemented control rats, 
DO: Offspring of non-supplemented diabetic rats, DO-OO: Offspring of Olive Oil-










different F0 mothers in each experimental group. Different letters denote significant 
differences between groups, p < 0.05. 
 
Fig. 3. Immunostaining of CTGF in the heart of 21-day-old female and male offspring 
from control and diabetic rats. Representative microphotographs of the ventricles and 
densitometry analysis are shown (400X). CO: Offspring of non-supplemented control 
rats, CO-OO: Offspring of Olive Oil-supplemented control rats, DO: Offspring of non-
supplemented diabetic rats, DO-OO: Offspring of Olive Oil-supplemented diabetic rats. 










experimental group. Different letters denote significant differences between groups, p < 
0.05. 
 
Fig. 4. Immunostaining of MMP-2 in the heart of 21-day-old female and male offspring 
from control and diabetic rats. Representative microphotographs of the ventricles and 
densitometry analysis are shown (400X). CO: Offspring of non-supplemented control 
rats, CO-OO: Offspring of Olive Oil-supplemented control rats, DO: Offspring of non-
supplemented diabetic rats, DO-OO: Offspring of Olive Oil-supplemented diabetic rats. 










experimental group. Different letters denote significant differences between groups, p < 
0.05. 
 
Fig. 5. Immunostaining of nitrated proteins, an index of peroxynitrite-induced damage 
in the heart of 21-day-old female and male offspring from control and diabetic rats. 
Representative microphotographs of the ventricles and densitometry analysis are shown 
(400X). CO: Offspring of non-supplemented control rats, CO-OO: Offspring of Olive 
Oil-supplemented control rats, DO: Offspring of non-supplemented diabetic rats, DO-










obtained from 7 rats from different F0 mothers in each experimental group. Different 
letters denote significant differences between groups, p < 0.05. 
 
Fig. 6. The production of NO (measured as the concentrations of nitrates/nitrites, stable 
NO metabolites) and lipoperoxidation (measured as TBARS concentrations) in the heart 
of 21-day-old female and male offspring from control and diabetic rats. A. 
nitrates/nitrites levels. B. TBARS concentrations. CO: Offspring of non-supplemented 
control rats, CO-OO: Offspring of Olive Oil-supplemented control rats, DO: Offspring 
of non-supplemented diabetic rats, DO-OO: Offspring of Olive Oil-supplemented 










mothers in each experimental group. Different letters denote significant differences 
between groups, p < 0.05. 
 
Fig. 7. Apoptosis in the heart of 21-day-old female and male offspring from control and 
diabetic rats. Representative microphotographs of the ventricles and densitometry 
analysis are shown (400X). Apoptotic cells were labeled in green. CO: Offspring of 
non-supplemented control rats, CO-OO: Offspring of Olive Oil-supplemented control 
rats, DO: Offspring of non-supplemented diabetic rats, DO-OO: Offspring of Olive Oil-










different F0 mothers in each experimental group. Different letters denote significant 













 CONTROL GROUP DIABETIC GROUP 
 Standard diet 
6% Olive oil- 
enriched diet 
Standard diet 
6% Olive oil- 
enriched diet 
Maternal data 94 ± 18 a 103 ± 18 a 228 ± 32 b 224 ± 37 b 
Female offspring 
data 
103 ± 16 a 101 ± 8a 110 ± 16 a 100 ± 11 a 
Male offspring data 99 ± 18a 107 ± 11 a 132 ± 16 b 82 ± 11 c 
Table 1. Glycemia values in control and diabetic rats (day 21 of pregnancy) and in their 21-day-old 
female and male offspring. Values represent mean ± SD obtained from 7 rats from different F0 mothers 
in each experimental group. Different letters denote significant differences between groups, p<0.05. 
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